Guided Therapeutics (GTHP) Interest Income - Net (2023 - 2025)
Guided Therapeutics recorded quarterly Interest Income - Net of -$157000.0 in Q2 2025, down 6.8% quarter-over-quarter from -$147000.0 in Q1 2025, and down 109.33% year-over-year from $1.7 million in Q2 2024.
Guided Therapeutics' Interest Income - Net history runs 3 years deep, the most recent figure standing at -$157000.0 for Q2 2025.
- In Q2 2025, Interest Income - Net fell 109.33% year-over-year to -$157000.0; the TTM figure through Jun 2025 stood at -$546000.0 (down 100.0% YoY), while the FY2024 annual figure was -$378000.0, down 38.97% from the prior year.
- Interest Income - Net came in at -$157000.0 for Q2 2025 at Guided Therapeutics, down from -$147000.0 in the prior quarter.
- In the past five years, Interest Income - Net ranged from a high of -$61000.0 in Q1 2024 to a low of -$157000.0 in Q2 2025.
- A 3-year average of -$95400.0 and a median of -$73000.0 in 2023 frame the typical range for Interest Income - Net.
- Across the five-year window, Interest Income - Net advanced 7.58% in 2024 and plunged 140.98% in 2025, its largest moves.
- Guided Therapeutics' Interest Income - Net stood at -$66000.0 in 2023, then tumbled by 103.03% to -$134000.0 in 2024, then slipped by 17.16% to -$157000.0 in 2025.
- According to Business Quant data, Interest Income - Net over the past three periods registered -$157000.0, -$147000.0, and -$134000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -157,000.00 |
| Mar 31, 2025 | -147,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Sep 30, 2024 | -108,000.00 |
| Jun 30, 2024 | -75,000.00 |
| Mar 31, 2024 | -61,000.00 |
| Dec 31, 2023 | -66,000.00 |
| Sep 30, 2023 | -71,000.00 |
| Jun 30, 2023 | -69,000.00 |
| Mar 31, 2023 | -66,000.00 |